ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.150,71
-0,10%
S&P 500
5.303,27
0,12%
US Dollar vs BRL
5,1046
0,00%
Bitcoin
67.306,63
0,34%
Brent Oil
83,76
0,00%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Beam Therapeutics Inc (BEAM)

  7. Beam Therapeutics Inc (BEAM) Notícias

BEAM

Beam Therapeutics (BEAM)

Beam Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:BEAM
DataHoraFonteTítuloCódigoCompanhia
14/05/202417:00GlobeNewswire Inc.Beam Therapeutics to Present Data Highlighting Robust Manufacturing Process for BEAM-101 at 2024 European Hematology Association (EHA) Hybrid CongressNASDAQ:BEAMBeam Therapeutics Inc
08/05/202407:30GlobeNewswire Inc.Beam Therapeutics to Participate in RBC Capital Markets 2024 Global Healthcare ConferenceNASDAQ:BEAMBeam Therapeutics Inc
07/05/202408:19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BEAMBeam Therapeutics Inc
07/05/202408:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BEAMBeam Therapeutics Inc
07/05/202407:30GlobeNewswire Inc.Beam Therapeutics Reports Pipeline Updates and First Quarter 2024 Financial ResultsNASDAQ:BEAMBeam Therapeutics Inc
26/03/202407:30GlobeNewswire Inc.Beam Therapeutics Announces Clearance of Clinical Trial Authorisation Application for BEAM-302 for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)NASDAQ:BEAMBeam Therapeutics Inc
28/02/202408:30GlobeNewswire Inc.Beam Therapeutics to Participate in Upcoming March 2024 Investor ConferencesNASDAQ:BEAMBeam Therapeutics Inc
27/02/202409:40Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BEAMBeam Therapeutics Inc
27/02/202409:22Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:BEAMBeam Therapeutics Inc
27/02/202408:30GlobeNewswire Inc.Beam Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Reiterates Anticipated MilestonesNASDAQ:BEAMBeam Therapeutics Inc
05/02/202408:30GlobeNewswire Inc.Beam Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceNASDAQ:BEAMBeam Therapeutics Inc
02/02/202418:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BEAMBeam Therapeutics Inc
31/01/202418:47Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BEAMBeam Therapeutics Inc
08/01/202408:30GlobeNewswire Inc.Beam Therapeutics Highlights Progress Across Base Editing Portfolio and Outlines 2024 Anticipated MilestonesNASDAQ:BEAMBeam Therapeutics Inc
02/01/202408:30GlobeNewswire Inc.Beam Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:BEAMBeam Therapeutics Inc
14/12/202308:30GlobeNewswire Inc.Beam Therapeutics Appoints Biotech Executive Christi Shaw to its Board of DirectorsNASDAQ:BEAMBeam Therapeutics Inc
08/11/202308:30GlobeNewswire Inc.Beam Therapeutics Reports Pipeline and Business Updates and Third Quarter 2023 Financial ResultsNASDAQ:BEAMBeam Therapeutics Inc
08/11/202308:30GlobeNewswire Inc.Beam Therapeutics to Participate in 2023 Jefferies London Healthcare ConferenceNASDAQ:BEAMBeam Therapeutics Inc
31/10/202307:59Dow Jones NewsBeam Therapeutics to Sell Rights in Verve Licensing Deal to Lilly for $250 Million UpfrontNASDAQ:BEAMBeam Therapeutics Inc
31/10/202307:00GlobeNewswire Inc.Beam Announces Agreement for Lilly to Acquire Beam’s Opt-In Rights to Verve Therapeutics’ Base Editing Programs for Cardiovascular DiseaseNASDAQ:BEAMBeam Therapeutics Inc
25/10/202307:30GlobeNewswire Inc.Beam Therapeutics Presents Preclinical Data Highlighting Utility and Durability of BEAM-301 to Correct a Glycogen Storage Disease Type I Deficiency Disease-Causing Mutation at ESGCTNASDAQ:BEAMBeam Therapeutics Inc
19/10/202309:45GlobeNewswire Inc.Beam Therapeutics Announces Portfolio Prioritization and Strategic Restructuring Focused on Potential Near-term Value Drivers and Long-term Growth of Precision Genetic Medicines PipelineNASDAQ:BEAMBeam Therapeutics Inc
07/09/202311:00GlobeNewswire Inc.Beam Therapeutics Presents Preclinical Data Highlighting Utility of BEAM-302 to Correct an Alpha-1 Antitrypsin (AAT) Deficiency Disease-Causing MutationNASDAQ:BEAMBeam Therapeutics Inc
05/09/202307:30GlobeNewswire Inc.Beam Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of BEAM-201 in Relapsed, Refractory T-ALL/T-LLNASDAQ:BEAMBeam Therapeutics Inc
31/08/202307:30GlobeNewswire Inc.Beam Therapeutics to Participate in Upcoming September Investor ConferencesNASDAQ:BEAMBeam Therapeutics Inc
08/08/202307:30GlobeNewswire Inc.Beam Therapeutics Reports Pipeline Updates and Second Quarter 2023 Financial ResultsNASDAQ:BEAMBeam Therapeutics Inc
08/06/202317:56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BEAMBeam Therapeutics Inc
08/06/202317:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BEAMBeam Therapeutics Inc
17/05/202307:30GlobeNewswire Inc.Beam Therapeutics to Participate in Upcoming May Investor ConferencesNASDAQ:BEAMBeam Therapeutics Inc
11/05/202307:30GlobeNewswire Inc.Beam Therapeutics to Participate in RBC Capital Markets 2023 Global Healthcare ConferenceNASDAQ:BEAMBeam Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:BEAM

Seu Histórico Recente

USOTC
OGSRW
Overseas Shipholding (PK)
NYSE
KAMN
Kaman
EU
SSKED
Euronext S Kering 070322...
NASDAQ
TWCBW
Bilander Acquisition
AQSE
NXQ.GB
Nexteq
LSE
1JD
1x Jd
BIT
UIJ449
Unicredit Bank
COIN
SAFUST
SafCoin
BIT
UIF429
Unicredit Bank
EU
7457T
7457T
TSXV
MDL
Medallion Resources
NASDAQ
VTIP
Vanguard Short Term Infl...
NASDAQ
LFAOX
LifeX Income Fund 1954F
NYSE
NUVB
Panacea Acquisition
ASE
MLSB3
MLS Innovation
EU
3456S
3456S
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados